Bleakley Financial Group, LLC Novartis Ag Transaction History
Bleakley Financial Group, LLC
- $3.32 Trillion
- Q4 2024
A detailed history of Bleakley Financial Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 53,363 shares of NVS stock, worth $5.59 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
53,363
Previous 51,136
4.36%
Holding current value
$5.59 Million
Previous $5.88 Billion
11.71%
% of portfolio
0.16%
Previous 0.18%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,434Shares Held
133MCall Options Held
1.12MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA12.2MShares$1.28 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.26 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$848 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$731 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$604 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $225B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...